echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alzherimer's&Dementia | The physical examination reports are all brain atrophy, but the outcome is very different!

    Alzherimer's&Dementia | The physical examination reports are all brain atrophy, but the outcome is very different!

    • Last Update: 2021-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Brain atrophy is an imaging diagnosis .


    Brain atrophy is an imaging diagnosis .


    Recent studies have shown that the classification of brain atrophy subtypes through structural MRI, so that it has a typical (ie hippocampus and neocortical associated area), hippocampus reserved area or edge-based atrophy pattern, can identify including Alzheimer's disease (AD) biological and clinically meaningful manifestations.


    Classification of brain atrophy subtypes by structural MRI, so that it has typical (ie hippocampus and neocortical associated areas), hippocampus reserved areas or marginal atrophy patterns, which can identify organisms including Alzheimer's disease (AD) Academic and clinically meaningful performance.


    At the same time, studies have suggested that brain atrophy subtypes are related to different cognitive declines in AD and AD prodromal phase.


    Since previous studies were mainly based on pathophysiological assumptions, the samples were limited to patients with amyloid (Aβ)-positive biomarkers, patients with amnestic mild cognitive impairment (MCI), and/or patients with dementia and AD clinical syndromes.


    To this end, the MENTOLT study led by experts from the Neurodegenerative Diseases and Neuroscience Research Center of the University of Bordeaux in France gave the answer, and the results were published in the latest Alzheimer' Dementia journal.


    During the 4-year follow-up period, a total of 213 cases of dementia occurred, with an incidence rate of 3.


    In the entire analysis sample and Aβ-positive participants, typical/diffuse brain atrophy was associated with faster cognitive decline.


    The incidence of dementia varies with atrophy subtypes.


    According to the type of brain atrophy, the linear mixed model is adjusted according to age, gender, education level and population status to adjust the cognitive changes in 4 years.


    According to the type of brain atrophy, the linear mixed model is adjusted according to age, gender, education level and population status to adjust the cognitive changes in 4 years.


    Typical/diffuse brain atrophy (HR=4.


    It can be seen that the classification of different regional atrophy subtypes is expected to predict different subsequent patterns of cognitive decline in patients and the conversion rate to different causes of dementia.


    references:

    Planche V, et al.


    onlinelibrary.
    wiley.
    com/doi/10.
    1002/alz.
    12231" target="_blank" rel="noopener">Clinical relevance of brain atrophy subtypes categorization in memory clinics.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.